INCY
Incyte Genomics Inc ·
—
Market cap
—
52-week range
—
Volume
—
Previous close
—
Incyte Genomics Inc (INCY) is held by 5 tracked hedge fund(s) and traded by 1 member(s) of Congress. Largest tracked holder: BAKER BROS. ADVISORS LP.
| Fund | % of portfolio | Shares | Value | Latest activity | Avg buy price | Date |
|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP |
16.6% | 30.7M | $2.9B | — | $72.27 | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC Jim Simons |
0.5% | 3.7M | $344M | ▼ 8.2% (−327K) | $72.59 | 2026-03-31 |
| AustralianSuper Pty Ltd AustralianSuper Pty Ltd |
0.6% | 1.1M | $107M | ▲ 77% (+496K) | $91.77 | 2026-03-31 |
| Gotham Asset Management, LLC Joel Greenblatt |
0.2% | 677K | $64M | ▲ 92% (+324K) | $85.98 | 2026-03-31 |
| ARMISTICE CAPITAL, LLC ARMISTICE CAPITAL, LLC |
1.1% | 657K | $62M | ▼ 40% (−441K) | $60.09 | 2026-03-31 |
FAQ ▾
Which hedge funds hold INCY?
Tracked holders include: BAKER BROS. ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, AustralianSuper Pty Ltd, Gotham Asset Management, LLC.
How much smart money owns INCY?
5 tracked hedge fund(s) and 1 member(s) of Congress have disclosed positions.
Are members of Congress trading INCY?
Yes — 1 member(s) have disclosed INCY trades. See the Congress tab.
Where does this data come from?
SEC 13F filings (funds), Form 4 (insiders) and STOCK Act reports (Congress).
Sourced from SEC 13F, Form 4 & STOCK Act filings · Not investment advice ▾
Ownership from SEC filings; price from market data.
Published by WealthFile · Not investment advice.